France Recalls Rare Disease Drug Tavneos After Deaths
8 Articles
8 Articles
This Wednesday, the drug agency announces the withdrawal of Tavneos from the French market. The benefit/risk ratio has become unfavourable. This medication is used in the treatment of rare inflammatory diseases of the blood vessels.
The National Medicines Agency follows an opinion of the European health authorities, following the reporting of several deaths abroad.
In the spring, the Kissei group, which markets Tavneos in Japan, reported about 20 deaths among patients treated since the introduction of the medicine into the Japanese market in 2022. In France, according to ANSM, it is prescribed to 600 patients.
Intended to treat certain rare autoimmune diseases, Tavneos was the subject of global alerts
Treats rare autoimmune diseases: France recalls rare disease drug Tavneos after deaths
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
![[Opinion] "Dangerous and Irresponsible": This Influential Mom Is Doing Her Gym Session at 9 p.m. with Her Baby Strapped Against Her and Polemics](/_next/image?url=https%3A%2F%2Fgrnd.b-cdn.net%2Finterests%2F7a7880f7faf0343af7d0ba96fb10b921e1562055.jpg&w=1440&q=75)
